Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) COO John Gallagher sold 431 shares of the business’s stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $25.35, for a total transaction of $10,925.85. Following the completion of the transaction, the chief operating officer owned 32,634 shares in the company, valued at $827,271.90. This trade represents a 1.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trupanion Price Performance
Shares of NASDAQ TRUP opened at $26.91 on Friday. The company has a market capitalization of $1.17 billion, a PE ratio of 45.61 and a beta of 1.39. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25. Trupanion, Inc. has a twelve month low of $21.16 and a twelve month high of $57.00. The firm has a fifty day simple moving average of $23.70 and a 200 day simple moving average of $28.10.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The business had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. During the same quarter in the prior year, the firm posted ($0.03) earnings per share. The business’s quarterly revenue was up 12.3% compared to the same quarter last year. On average, sell-side analysts forecast that Trupanion, Inc. will post 0.54 EPS for the current year.
Hedge Funds Weigh In On Trupanion
Analyst Upgrades and Downgrades
TRUP has been the subject of several recent analyst reports. Stifel Nicolaus set a $28.00 target price on Trupanion in a research note on Friday, June 26th. Weiss Ratings reissued a “sell (d+)” rating on shares of Trupanion in a research note on Monday, June 1st. Cantor Fitzgerald cut their price target on Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a report on Thursday, April 9th. Finally, Bank of America cut their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Two analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $41.50.
Check Out Our Latest Stock Report on TRUP
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Articles
- Five stocks we like better than Trupanion
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
